← Back to Search

AN-BP for Esophageal Cancer

N/A
Waitlist Available
Led By Dennis J Gibson, MD
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors

Eligible Conditions
  • Esophageal Cancer
  • Eating Disorders
  • Barrett's Esophagus
  • Rumination Syndrome
  • Anorexia Nervosa
  • Vomiting

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of patients positive for BE

Trial Design

1Treatment groups
Experimental Treatment
Group I: AN-BPExperimental Treatment1 Intervention
individuals with a dx of AN-BP, with a \>5-year history of purging, with a frequency of at least once a day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EsoGuard
2020
N/A
~150

Find a Location

Who is running the clinical trial?

Lucid Diagnostics, Inc.Industry Sponsor
6 Previous Clinical Trials
1,727 Total Patients Enrolled
Denver Health and Hospital AuthorityLead Sponsor
104 Previous Clinical Trials
402,096 Total Patients Enrolled
Dennis J Gibson, MDPrincipal InvestigatorDenver Health and Hospital Authority
~17 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top